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Gastric cancer is one of the most common cancers in the world
(Parkin et al, 1988). A better understanding of its molecular
mechanisms is needed to establish of effective methods for
managing patients with this disease. In gastric cancers, activation
of K-ras, c-met, K-sam, c-erbB-2 and EGFR (Deng et al, 1987;
Yokota et al, 1988; Hattori et al, 1990; Kameda et al, 1990; Tahara,
1990; Kuniyasu et al, 1992; Hirono et al, 1995), and inactivation
of APC, p53, DCC and FHIT (Tamura et al, 1991; Horii et al,
1992; Nakatsuru et al, 1992; Barletta et al, 1993; Ohta et al, 1996)
have been reported so far. Frequent loss of heterozygosity (LOH)
in gastric cancer on chromosome arms 1p, 3p, 5q, 7q, 11p, 11q,
12q, 17p and 18q has suggested the involvement of mutations in
several tumour suppressor genes in this disease (Sano et al, 1991;
Uchino et al, 1992; Ranzani et al, 1993; Kuniyasu et al, 1994;
Schneider et al, 1995; Baffa et al, 1996; Ezaki et al, 1996).
On chromosome 16, Gleeson et al (1997) reported frequent
allelic losses on almost entire 16q arm in diffuse type gastric
cancer, but no detailed analysis of 16q in gastric cancer has yet
been done other than the studies on E-cadherin, which is located at
16q22.1 (Shiozaki et al, 1991; Guilford et al, 1998). Frequent
LOH on 16q22–q24 have been reported in many other tumours of
the liver, ovary, breast, prostate and salivary gland as well as infant
brain tumours and non-small cell lung cancer (Sato et al, 1990,
1991; Nishida et al, 1992; Tsuda et al, 1994; Dorion-Bonnet et al,
1995; Iwabuchi et al, 1995; Braeker et al, 1996; Johns et al, 1996;
Elo et al, 1997; Latil et al, 1997; Sato et al, 1998a). In this study,
we analysed allelic loss on chromosome bands 16q22–q24 in 24
gastric cancer specimens and identified three regions of common
allelic loss; the highest frequency of allelic loss was observed at
D16S534 in 16q24.2 (63%). The H-cadherin gene maps to this
region. This gene is a new member of the cadherin family and has
been identified as a tumour suppressor gene associated with breast
cancer: loss of expression has been observed immunohistochemi-
cally in invasive breast cancer tissues, and transfection of its
cDNA suppressed some neoplastic phenotypes (Lee, 1996). Thus
it is of great interest to investigate the expression and genetic
alterations of this gene in gastric cancer.
MATERIALS AND METHODS
Tissue samples and DNA extraction
Paired normal and cancerous tissues from 24 Japanese patients
with gastric cancer (18 intestinal type and six diffuse type, 14
males and ten females) were obtained during surgery at Tohoku
University Hospital (Sendai, Japan) and its related hospitals
(Sendai, Japan) during the period from March 1995 to May 1996.
Histopathological classifications were defined according to WHO
criteria (1990). Clinical and pathological stages were determined
by the Japanese Research Society of Gastric Cancer (JRSGC)
(1981). Brief information on the clinical staging system of JRSGC
was included in our previous report (Ouyang et al, 1997). None of
these patients had family history for gastric cancer in first-degree
relatives. In each case, tumour tissue and normal mucosa were
separately collected, frozen in liquid nitrogen immediately after
resection and stored at –80°C until use. DNA extraction was
performed according to methods described previously (Sato et al,
1990). Details of the patients and their tumours are summarized in
Table 1.
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Gastric cancer cell lines
Three cell lines, AZ521 (Imanishi et al, 1989), MKN7 (Yokota et
al, 1988) and KatoIII (Nakatani et al, 1990), all derived from
gastric cancer tissues, were used as sources of DNAs and RNAs.
These cell lines were obtained from Cancer Cell Repository,
IDAC, Tohoku University (Sendai, Japan). DNA extraction was
performed as described above. RNAs were extracted as described
previously (Nakamura et al, 1984).
LOH analysis
A total of 14 microsatellite markers, listed in Figure 2, were used
in the present study. Nucleotide sequence of the primers and
detailed polymerase chain reaction (PCR) conditions were
described previously (Sato et al, 1998a). Each product was run on
a 3% agarose gel to check the concentration of the PCR product,
diluted with a 2- to 20-fold volume of 95% formamide/0.25%
methyl-violet according to its concentration, and denaturated at
80°C for 10 min. These samples were electrophoresed in 6%
Long-Ranger™ (FMC Bio Products, Rockland, ME, USA)/6 M
urea gels and analysed by ALFred DNA Sequencer with Fragment
Manager™ software (Pharmacia Biotech, Uppsala, Sweden). We
defined allelic loss as occurring when more than a 50% reduction
in the area of a peak was calculated in the tumour when compared
with that of corresponding normal tissue. At least two independent
experiments were performed to confirm the results.
Fluorescence in situ hybridization (FISH) analysis
Two-colour FISH was performed with cosmid clones labelled
with either biotin-16-dUTP or digoxigenin-11-dUTP according
to methods described previously (Fukushige et al, 1997). To
eliminate background noise due to repetitive sequences,
0.15 mg ml–1 of COT-1™ DNA (GIBCO BRL, Gaithersburg, MD,
USA) was added. A centromeric plasmid probe, RMC16L007, an
alpha satellite clone of chromosome 16, and a cosmid clone
located at either D16S422 or D16S534 were used as probes.
RMC16L007 was obtained from the Resource for Molecular
Cytogenetics, LBNL/UCSF (Greig et al, 1989; Sato et al, 1998a).
Allelic deletions were assessed by counting of signals for
centromeric and cosmid probes in more than 50 nuclei.
Analysis of expression pattern of the H-cadherin gene
Expression of the H-cadherin gene was analysed using three
gastric cancer cell lines and normal gastric mucosae from two
individuals by reverse transcription coupled with polymerase
chain reaction (RT-PCR) as described previously (Mori et al,
1997). Expression of the actin gene was monitored as the control.
Conditions for the PCR amplifications were as follows: 94°C for
2 min for the initial denaturation followed by 30 cycles of 94°C for
30 s, 55°C for 30 s and 72°C for 30 s. The final elongation was at
72°C for 5 min. The amplified products were electrophoresed
in 3% agarose gels, transferred to nylon membranes, and
hybridized with 32P end-labelled oligonucleotide probes.
Nucleotide sequences of the PCR primers and the oligonucleotide
probe were shown in our previous work (Sato et al, 1998b).
Mutation analysis of the H-cadherin gene
We searched for mutations of the H-cadherin gene in 24 primary
gastric cancer tissues and three gastric cancer cell lines. As the
first screening in this search, PCR-SSCP (single-strand conforma-
tion polymorphism) was performed in all of the coding exons, as
well as their surrounding regions and the 5¢-flanking region as
Table 1 Characteristics of patients
No. Sex Age Histologya Stage T N M Depthb lyc vd ne
25 F 62 I IA 1 0 0 m 0 0 0
26 M 66 I IA 1 0 0 m 0 0 0
81 M 61 I IA 1 0 0 sm 0 0 0
146 M 78 I IA 1 0 0 sm 0 0 0
48 M 68 I IA 1 0 0 sm 1 0 0
29 F 53 I IB 2 0 0 mp 1 0 0
43 M 68 I IB 2 0 0 mp 1 0 0
24 M 66 I IB 2 0 0 mp 1 2 0
77 M 73 I IB 2 0 0 mp 2 1 0
84 F 68 I IB 2 0 0 ss 0 0 0
94 M 50 I IB 2 0 0 ss 1 0 0
58 M 64 I II 3 0 0 se 2 1 0
67 M 50 I IIIA 2 2 0 ss 0 0 2
85 F 63 I IIIA 3 1 0 se 1 2 1
79 M 79 I IIIB 3 2 0 se 2 0 2
97 F 72 I IV 3 0 1 (peritoneum) se 2 1 0
76 M 74 I IV 3 2 1 (liver) se 2 1 2
45 F 75 I IV 4 2 0 se 2 2 2
73 M 45 D IA 1 0 0 m 0 0 0
55 F 71 D IA 1 0 0 sm 0 0 0
88 F 43 D II 2 1 0 ss 1 0 1
98 F 55 D II 3 0 0 se 0 0 0
78 F 50 D IIIA 2 2 0 ss 2 1 2
23 M 74 D IV 4 2 1 (peritoneum) se 3 3 2
aI, intestinal type of gastric cancer; D, diffuse type of gastric cancer. bm, mucosa; sm, submucosa; mp, muscularis propria; ss, subserosa;
se, serosa exposed. cly, lymphangial invasion. dv, vascular invasion. en, nodal metastasis. M, male; F, female.558 Y Mori et al
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Figure 1 Typical examples of microsatellite analyses. (A) Profiles of the electrophoreses of PCR products derived from tumours and their corresponding
normal tissues of cases 29, 76 and 98 are shown. Loci analysed are indicated at the bottom of each set of profiles. Allelic losses are indicated by arrows: case
29 at D16S518, case 76 at D16S402 and case 98 at D16S534. Retention of heterozygosities were observed at D16S504 (case 29), D16S422 (case 76) and
D16S516 (case 98). T (upper column) and N (lower column) denote DNA samples of tumour and corresponding normal tissues, respectively (Continued)Frequent loss of 16q24 in human gastric cancer 559
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described by Orita et al (1989) with some modifications (Mayama
et al, 1997). Aberrant bands were collected and the DNAs were
purified for the second PCR amplification and sequencing.
Analyses of methylation status of the 5¢-region of the
H-cadherin gene by methylation specific PCR
Ten primary gastric cancer tissues, three gastric cancer cell lines
and two normal gastric mucosae were analysed for methylation
status of the 5¢ -flanking region of the H-cadherin gene. DNAs
were modified with sodium bisulphite and analysed according to
Herman’s method (1996) with some modifications (Sato et al,
1998b). Nucleotide sequences of the primers used in this study
are: HCADMF. 5¢-CGCGGGGTTCGTTTTTCGC-3’; HCADMR,
5¢-GACGTTTTCATTCATACACGCG-3¢; MSP, 5¢-CTAATAAC-
CAAAACCAATAACTTTA-3¢.
RESULTS
Allelotype analysis
Typical examples of the microsatellite analyses are shown in
Figure 1A. T and N denote PCR-amplified DNA samples of
tumour and corresponding normal tissues, respectively, and the
primer sets used are shown at the bottom. An allelic loss was iden-
tified at D16S518 in case 29, indicated by an arrow. Similarly, in
cases 76 and 98, LOH at D16S402 and D16S534, respectively,
was obvious, as indicated by arrows. Results of microsatellite
analyses are summarized in Figure 2. Although the number of
samples analysed was not very large, three distinct regions of
common allelic loss were found: we named them as G1 through
G3 in order from centromeric to telomeric. Markers and their
genetic distances according to Doggett et al (1995) are also shown.
We also analysed a CA dinucleotide marker in intron 1 of the H-
cadherin gene that is between D16S422 and D16S402 (Sato et al,
1998c), to determine the telomeric border of G2. However, only a
few cases were informative and the results did not contribute to the
determination of the border of the region G2. Twelve (50%) of the
24 tumours showed allelic imbalances (AIs), presumably LOHs, at
one or more loci.
Microsatellite instability (MSI) at two or more loci was
observed in three (12.5%) of 24 tumours; two cases (8.3%)
showed MSIs at most of the loci tested. These results are consis-
tent with previous studies (Kuniyasu et al, 1994; Schneider et al,
1995; Ezaki et al, 1996).
Since we did not have large enough tissue volumes of these
gastric cancers, we could not perform FISH or other methods with
which to study whether the AIs really reflect LOHs. Instead, we
analysed allelic loss at this region in three gastric cancer cell lines
(AZ521, MKN7 and KatoIII) by FISH. One cell line (MKN7)
exhibited an allelic loss when genomic cosmid clone harbouring
D16S534 was used as the probe for FISH. MKN7 retained the
alleles at both D16S402 and D16S422 loci in 16q24 (data not
shown).
In this study, the locus most frequently lost was D16S534
(63%), and three common regions of allelic loss were identified:
G1, an 18-cM region between D16S496 and D16S518; G2, a 3-cM
region between D16S505 and D16S402; and G3, a region distal
from D16S520 (see Figure 2). The incidence of LOH at D16S496,
the locus for the E-cadherin gene, which has been reported to be
inactivated in some gastric cancers of diffuse type (Shiozaki et al,
1991) as well as in some familial gastric cancers (Guilford et al,
1998), was not very high (2/5 in diffuse type and 3/10 in intestinal
type).
Figure 1 Cont (B) Light microscopic features of the tumours; a, case 29, intestinal type; b, case 76, intestinal type; c, case 98, diffuse type (x80, haematoxylin
and eosin staining).
Table 2 Characteristics of patients with and without LOH in region G2
LOH + LOH –
Age
60≤ 86 P = 0.574
60> 3 3
Sex
M8 5 P = 0.370
F3 4
Histologic subtype
Ia 86 P = 0.574
Da 33
Pathologic features
lyb –1 5 P = 0.038
+1 0 4
vb –4 7 P = 0.080
+7 2
nb –8 4 P = 0.205
+3 5
Depth
~smb 14 P = 0.098
mp~b 10 5
aI, interstitial type of gastric cancer; D, diffuse type of gastric cancer. bly,
lymphangial invasion; v, vascular invasion; n, nodal metastasis; sm,
submucosa; mp, muscularis propria. M, male; F, female.
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Clinicopathologic features of the cases that showed LOHs in G2
are summarized in Table 2. Statistical analysis was done by
Fisher’s exact test. LOHs at this region did not significantly corre-
late with age, sex, or histologic subtype. Cases that showed LOHs
at G2 correlated with lymphangial invasion (P = 0.038). Although
it was not significant, G2 LOH tended to be high in tumours with
vascular invasion as well as invasion into the gastric wall.
Analysis for the alterations of the H-cadherin gene in
gastric cancer
One of the putative tumour suppressor genes located at G2 was
H-cadherin, a newly isolated adhesion molecule in the cadherin
family. This gene has been reported to have relationships with
tumour cell invasion in breast cancers (Lee, 1996). Thus, it is one
candidate for a tumour suppressor gene for gastric cancers. We
next analysed the expression and genetic alterations of this gene.
RT-PCR was performed to determine the expression of H-
cadherin in normal gastric mucosae from two individuals as well
as in three gastric cancer cell lines (AZ521, MKN7 and KatoIII).
A decrease in H-cadherin expression was observed in all three
gastric cancer cell lines when compared to normal gastric tissue
(Figure 3). Northern hybridization was also performed, and we
confirmed the results of RT-PCR (data not shown).
We then searched for genetic alterations in the entire coding
region as well as for exon–intron boundaries of the H-cadherin
gene. PCR-SSCP and genomic DNA sequencing were used for
detection of mutations, but none were observed.
We further analysed the methylation status of the 5¢-flanking
region of H-cadherin (nucleotide position from –265 to –25) in ten
gastric cancer tissues and the three gastric cancer cell lines
Figure 2 Results of the microsatellite analysis. (l l), retention of heterozygosity; (l), loss
of heterozygosity (LOH); –, not informative; M, microsatellite instability (MSI). Hatched
boxes also indicate the lost regions. G1, G2, and G3 denote regions of common allelic
loss. Regions previously reported to be frequently lost in each type of tumour are also
shown on the right. In most of the cases, markers used in studies by others were different
from ours. Relative location of the deleted region was indicated by each bar: prostate
cancer (Elo et al, 1997; Latil et al, 1997); breast cancer (Sato et al, 1991; Tsuda et al,
1994; Dorion-Bonnet et al, 1995); brain tumour (Braeker et al, 1996); lung cancer (Sato et
al, 1998a); salivary gland tumour (Johns et al, 1996); hepatocellular carcinoma (Nishida et
al, 1992); ovarian cancer (Sato et al, 1990; Iwabuchi et al, 1995).
123456
H-cadher in
Actin
Figure 3 Results of RT-PCR analysis of gastric cancer cell lines and
normal gastric mucosae. Lanes 1 and 2: normal gastric mucosae derived
from different individuals; lanes 3, 5 and 6: gastric cancer cell lines AZ521,
KatoIII and MKN7; lane 4: a mixture of actin and H-cadherin cDNA clones as
the positive control.
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Figure 4 Results of methylation-specific PCR analysis of the 5¢-flanking
region of the H-cadherin gene using methylated-DNA-specific primers. An
arrow indicates signals derived from the methylated allele. Lane 1: negative
control (water); lanes 2 and 3: normal gastric mucosae; lanes 4–13: gastric
cancer tissues (cases 29, 45, 67, 76, 79, 81, 84, 85, 94 and 98); lanes
14–16: gastric cancer cell lines (MKN7, AZ521 and KatoIII); lane 17:
unmodified genomic DNA extracted from the peripheral blood cells of a
normal volunteer; lane 18: positive control.(AZ521, MKN7 and KatoIII), as well as two normal gastric
mucosae. Since there was no restriction site suitable for detection
of methylation status in this gene, we performed methylation
specific PCR analysis (Herman et al, 1996). All of the tumour
samples and normal tissues had methylated alleles (Figure 4).
DISCUSSION
In this study, we analysed 16q22–q24 and observed frequent
allelic loss (63% at maximum): three commonly deleted regions
were identified, although the number of tumours analysed was not
large. LOH of these regions was associated with microscopic
invasion, especially that to the lymphangial tract. Gleeson et al
(1997) reported that LOH on 16q is more frequently observed in
gastric cancers of the diffuse type (78%) than those of the
intestinal type (27%). Our results, however, found no significant
difference between them. The differences may be accounted for
the limited number of tumours analysed in these studies.
Alternatively, different genetic backgrounds and/or carcinogens
due to different environmental conditions and/or lifestyles may
cause these differences.
Frequent allelic losses in the 16q arm have also been reported in
invasive breast cancers and metastatic prostate cancers. It has been
suggested that inactivation of the same tumour suppressor gene in
this region may play a role in these types of cancers, resulting in
invasion and/or metastasis.
The G2 region was the locus of the most frequent loss in this
study (63% at D16S534). This high frequency of allelic loss
suggested the localization of a tumour suppressor gene that plays
an important role in the genesis and/or progression of gastric
cancer. Allelic losses of the G2 region are also reported in cancers
of the breast and prostate, as well as in mucoepidermoid tumour of
the salivary gland and infant brain tumour. More than ten
expressed sequence tags (ESTs) map to this region. Among these,
H-cadherin, 17b-hydroxysteroid dehydrogenase type II, transcrip-
tion factor SL-1, and phosphatidylinositol-4,5-biphosphate phos-
phodiesterase g 2 are identified to some extent. In this study, we
extensively analysed the H-cadherin gene, an adhesion molecule.
We selected this gene because it was localized in the G2 region and
included D16S534 and D16S422 within its introns (Sato et al,
1998b). Although all of the three gastric cancer cell lines examined
expressed markedly reduced levels of H-cadherin mRNA, no
mutation or difference in methylation status of the 5¢ non-coding
region was found. Perhaps a cis-acting element(s) of this gene
lies more upstream than the region examined. Alternatively,
the primary lesion could be a trans-acting element(s) of the H-
cadherin gene. It would be of great interest to investigate whether
or not demethylation of the H-cadherin gene has an effect on
gastric cell proliferation. There is another possibility that some
tumour suppressor gene(s) other than the H-cadherin gene may
remain undiscovered in this region.
Two other regions were also identified as loci of frequent allelic
loss. The G1 region (between D16S496 and D16S518) overlapped
those of frequent allelic loss in cancers of the breast and prostate.
Chromosomal rearrangement involving 16q is observed frequently
in acute myelogenous leukaemia (AML) and some prostate cancer
cell lines. The break point for both tumour types is located in
16q22, and the core binding factor b and the hpr genes are
involved in AML and prostate cancer, respectively (Shurtleff et al,
1995; Veronese et al, 1996).
A previous report showed that the E-cadherin gene was inacti-
vated in some diffuse-type gastric cancers. Moreover, this gene
was found to be responsible for some familial gastric cancers.
According to our results, this gene was localized at the flank of the
region G1. It has been suggested that mutations of the E-cadherin
gene might associate with a subset of sporadic gastric cancers.
Region G3 (distal from D16S520) also overlapped those of
frequent allelic loss in cancers of the breast, prostate, ovary and
liver. However, region G3 is localized very close to the telomere of
chromosome 16q, and the LOH at this region might merely be the
result of non-specific chromosome deletion with little, if any,
biological significance in gastric carcinogenesis.
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